Advances in Lung Cancer

Advances in Lung Cancer

ISSN Print: 2169-2718
ISSN Online: 2169-2726
www.scirp.org/journal/alc
E-mail: alc@scirp.org
"A Phase II Study of Erlotinib in Patients with Previously Treated Non-Small Cell Lung Cancer"
written by Tetsuya Kubota, Yoshio Okano, Mizu Sakai, Takashi Yamane, Naoki Shiota, Hiroshi Ohnishi, Hisanori Machida, Nobuo Hatakeyama, Eiji Takeuchi, Tomoyuki Urata, Fumitaka Ogushi, Akihito Yokoyama,
published by Advances in Lung Cancer, Vol.3 No.1, 2014
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Erlotinib: A Targeted Anticancer Drug
Current Cancer Therapy Reviews, 2017
Free SCIRP Newsletters
Copyright © 2006-2021 Scientific Research Publishing Inc. All Rights Reserved.
Top